Drug firm Zydus Cadila on Friday said it has received final approval from the US health regulator to market Fingolimod capsules and Verapamil Hydrochloride Injection. Fingolimod capsules is indicated for the treatment of patients with relapsing forms of multiple sclerosis.To Contact Insurance and Investment Expert
Thanks for reading. Please Share, Comment, Like the post And Follow, Subscribe Insurance and Investment News
from Source
Zydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection
![Zydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection]()
Reviewed by Insurance Advisor
on
October 16, 2020
Rating:
No comments: